# The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

> **NCT03164005** · — · COMPLETED · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 194 (actual)

## Conditions studied

- Obesity
- Metabolic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03164005
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-20
- **Primary completion:** 2017-09-01
- **Final completion:** 2018-03-01
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164005, "The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03164005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*